Mesenchymal stromal/stem cells (MSCs) possess multi-lineage differentiation and self-
renewal potentials. MSCs-based therapies have been widely utilized for the treatment of …

Stroke remains a major cause of long-term disability and mortality worldwide. The immune
system plays an important role in determining the condition of the brain following stroke. As …

Photoreceptor apoptosis is recognized as one key pathogenesis of retinal degeneration, the
counteraction of which represents a promising approach to safeguard visual function …

Stem cells are a versatile source for cell therapy. Their use is particularly significant for the
treatment of neurological disorders for which no definitive conventional medical treatment is …

Characterised by intraocular inflammation, non‐infectious uveitis includes a large group of
autoimmune and autoinflammatory diseases that either involve the eye alone or have both …

The severity and long-term consequences of brain damage in traumatic brain injured (TBI)
patients urgently calls for better neuroprotective/neuroreparative strategies for this …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by a
dysfunction of the immune system. Mesenchymal stromal cell (MSCs) derived extracellular …

Due to their characteristics, mesenchymal stem cells (MSCs) are considered a potential
therapy for brain tissue injury or degeneration. Nevertheless, despite the promising results …

Stroke causes varying degrees of neurological deficits, leading to corresponding
dysfunctions. There are different therapeutic principles for each stage of pathological …

Glaucoma is the major cause of irreversible blindness in the world characterized by
progressive retinal neurodegeneration, in which local inflammation in retina is involved in …